Hardware Podcasts

150 - Ocular/Ophthalmic Drug Delivery, Intravitreal Administration, Glaucoma, WetAMD, Vision, Range and Presence with Maysaa Attar

Let's Combinate · 21 Aug 2024 · 38m

What this episode covers

Maysaa Attar, Senior Vice President of R&D at Bausch + Lomb, explains the unique challenges of ocular drug delivery, noting that the eye’s anatomy acts as a formidable barrier requiring combination products to achieve efficacious concentrations. She details the risks of intravitreal injections, such as endophthalmitis, and the regulatory complexities involving human factors studies for devices like syringes and bioerodable implants. Attar also discusses innovations in treating glaucoma and wet AMD, including drug-eluting stents and intraocular lenses, while emphasizing the personal impact of vision loss on patients.

Most relevant to

large enterprises

Topics

Mentioned

Companies
Bausch + Lomb, Allergan, AbbVie
Products
Ozurdex
Also
USC

Related episodes from other shows

Other shows on the same ground, closest first.

  • Being an Engineer · 59m

    S5E27 Andy Schieber | Work Ethic, Medical Device Commercialization, & Ophthalmology Devices

    Andy Schieber, founder of Ingenarious Consultants and Head of Engineering at Rivermark Medical, discusses his journey from a farm upbringing to leading early-stage medical device development. He explains the challenges of commercializing Class III implantable devices, emphasizing the need to balance inventor vision with engineering feasibility and manufacturing constraints. Schieber advises young engineers to join startups rather than large corporations to gain broad experience and take risks, and highlights emerging innovations in ophthalmology such as stem cell and gene therapy delivery systems.

    Medical & health devicesStarting a product company
    7 chapters

  • Being an Engineer · 43m

    S5E25 Erica Kahn | Ophthalmology Device Design & Being Laid Off

    Erica Kahn, a biomedical engineer formerly of Ocular Therapeutix, discusses her work developing hydrogel technologies for treating wet macular degeneration and her recent unexpected layoff. She explains how her team used Higuchi kinetics modeling to accelerate formulation development for a sustained-release drug implant, bypassing lengthy in vivo studies. Kahn shares her emotional journey through job loss, emphasizing the importance of leveraging professional networks via LinkedIn and maintaining 'kindergarten skills' like empathy to secure support and new opportunities.

    Careers & educationMaterials & manufacturing processes
    7 chapters

  • Robot Talk · 21m

    Episode 101: Microscopic surgical robots - Christos Bergeles

    Christos Bergeles, a professor at King's College London, discusses his Robotics and Vision in Medicine Lab's development of microscopic surgical robots for delivering regenerative therapies deep inside the human body. He details a specific project targeting age-related macular degeneration, where a robotic system delivers stem cells to the retina with microscale precision, currently progressing toward first-in-human evaluation under ISO 13485 standards. Bergeles also explains how computer vision enables autostabilization to compensate for patient movement during awake eye surgery and addresses the ethical and data ownership challenges of autonomous surgical systems.

    Robotics & autonomyMedical & health devices
    8 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.